Pharmaceuticals

The Rise Of Innovation In COVID-19 Therapies On Oral Antiviral Treatments By Major Pharmaceutical Companies Is Influencing The Pediatric Vaccine Market

May 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Projected Increase In Market Value Of The Pediatric Vaccine Market During 2026–2030?

The pediatric vaccine market has experienced significant expansion in recent years. It is forecast to grow from $57.51 billion in 2025 to $65.01 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 13.0%. The historical growth of this market can be attributed to the increasing prevalence of preventable childhood diseases, government-led immunization initiatives, advancements in vaccine adjuvants, a rising awareness of pediatric health, and the expansion of cold chain infrastructure.

The pediatric vaccine market is projected to experience substantial growth over the coming years. This market is anticipated to reach a valuation of $107.8 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.5%. Key drivers for this expansion during the forecast period include advancements in mRNA and DNA vaccine technologies, rising investments in pediatric vaccine research and development (R&D), the incorporation of digital health monitoring, the broadening of healthcare infrastructure in developing markets, and collaborations between biotechnology companies and global health bodies. Prominent trends expected throughout the forecast horizon encompass a greater emphasis on ensuring vaccine availability in lower-income areas, a growing acceptance of combination vaccines, the widening of school-based immunization initiatives, the creation of new pediatric vaccines for uncommon diseases, and an increase in public-private collaborations for vaccine research.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2824&type=smp

Which Strong Drivers Are Impacting The Pediatric Vaccine Market Growth?

The growing incidence of chronic diseases, such as tuberculosis, diphtheria, and pneumonia, in individuals aged 15 years and younger, is projected to drive the expansion of the pediatric vaccines market. Children and adolescents already managing chronic conditions face an elevated risk of severe outcomes and complications from infectious diseases. For illustration, data from June 2024, provided by the National Health Service, a UK government body, revealed that 3,615,330 individuals registered with a general practitioner were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, indicating an 18% surge from 3,065,825 cases recorded in 2022. Consequently, the increasing prevalence of chronic diseases is a primary catalyst for the growth of the pediatric vaccine market.

How Is The Pediatric Vaccine Market Segmented Across Different Segment Categories?

The pediatric vaccine market covered in this report is segmented –

1) By Vaccine Type: Monovalent, Multivalent

2) By Technology: Live Attenuated, Inactivated, Toxoid, Conjugate, Other Technologies

3) By Application: Infectious Disease, Allergy, Cancer

Subsegments:

1) By Monovalent: Single Antigen Vaccines, Specific Disease Vaccines

2) By Multivalent: Combination Vaccines, Polyvalent Vaccines

Which Trends Are Guiding The Direction Of The Pediatric Vaccine Market?

Leading companies in the pediatric vaccine market are concentrating on securing product approvals to better fulfill the requirements of their existing consumers. ABRYSVO is a vaccine sanctioned by the FDA for administration to pregnant women to prevent lower respiratory tract disease (LRTD) and severe LRTD caused by respiratory syncytial virus (RSV) in children till 6 months of age. For instance, in August 2023, Pfizer Inc., a US-based pharmaceutical manufacturing company, announced the U.S. FDA approval of its ABRYSVO vaccine for the Avoidance of Respiratory Syncytial Virus (RSV) in Infants via active immunization of pregnant women 32-36 weeks gestational age. This represents the first and only maternal vaccination approved in the United States aimed at helping protect newborns against lower respiratory tract illness (LRTD) and severe LRTD caused by RSV from birth to six months of age.

Which Organizations Play A Role In The Pediatric Vaccine Market Landscape?

Major companies operating in the pediatric vaccine market are Merck & Co. Inc., Serum Institute of India Pvt. Ltd., Sanofi SA, Pfizer Inc., GlaxoSmithKline PLC, Sinovac Biotech Ltd, Zydus Cadila, Indian Immunologicals Limited, Panacea Biotec, Takeda Pharmaceutical Company, Daiichi Sankyo, CSL Limited, Sinopharm, Walvax Biotechnology, Fosun Pharma, MCM Vaccine Company, Seqirus, Johnson & Johnson, Connaught Laboratories Inc., Wyeth-Ayerst, Ataulfo de Paiva Foundation, Bio-Manguinhos – Institute of Technology on Immunobiologicals, Butantan Institute, Ezequiel Dias Foundation (FUNED), Sinergium

Get The Full Pediatric Vaccine Market Report:

https://www.thebusinessresearchcompany.com/report/pediatric-vaccine-global-market-report

Which Region Leads The Pediatric Vaccine Market In Terms Of Market Share?

North America was the largest region in the pediatric vaccine market in 2025. Middle East is expected to be the largest growing region in the global pediatric vaccine market share during the forecast period. The regions covered in the pediatric vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Pediatric Vaccine Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/pediatric-vaccine-global-market-report

Browse Through More Reports Similar to the Global Pediatric Vaccine Market 2026, By The Business Research Company

Pediatric Vaccine Market Report 2026

https://www.thebusinessresearchcompany.com/report/pediatric-vaccine-global-market-report

Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report

Adult Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/adult-vaccines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795